Levodopa effect on spontaneous speech in Parkinson's disease

被引:1
|
作者
Bayram, Ece [1 ]
Aslanbaba, Eda [2 ]
Akbostanci, Muhittin Cenk [1 ,2 ]
机构
[1] Ankara Univ, Dept Interdisciplinary Neurosci, Ibni Sina Hastanesi, Talatpasa Bulv 82, TR-06230 Ankara, Turkey
[2] Ankara Univ, Dept Neurol, Ibni Sina Hastanesi, Talatpasa Bulv 82, TR-06230 Ankara, Turkey
关键词
Levodopa; Word production; Verb; Noun; Parkinson's disease; MONTREAL COGNITIVE ASSESSMENT; NONDEMENTED PATIENTS; DIAGNOSTIC-CRITERIA; VERB GENERATION; TASK; STIMULATION; FLUENCY; MOTOR; MOCA;
D O I
10.1016/j.jneuroling.2019.03.001
中图分类号
H0 [语言学];
学科分类号
030303 ; 0501 ; 050102 ;
摘要
Parkinson's disease (PD) is associated with verb deficits detected with tasks including picture naming and verbal fluency. However, these deficits are not frequently reported by the patients themselves. Levodopa, the gold standard for motor symptoms in PD, has been previously implicated to improve these verb deficits. We evaluated the effect of levodopa by using a spontaneous speech task which is more naturalistic than the previously used tasks to detect verb deficits. Thirty PD patients, and 30 age-, gender-, years of education-matched healthy controls were included. Patients were tested while motor 'on' and 'off. Levodopa did not affect spontaneous speech, although it improved the motor symptoms. Compared to controls, PD patients produced shorter and a lower number of sentences. The verb deficit was independent of cognitive or motor performance. The pathophysiology of motor symptoms and verb deficits most likely differ, and levodopa does not improve verb deficits during spontaneous speech.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [31] Parkinson's disease - Levodopa complications
    King, DB
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 : S13 - S20
  • [32] Levodopa for Parkinson's Disease.
    Devos, David
    Moreau, Caroline
    Destee, Alain
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (09): : 935 - 936
  • [33] Levodopa Fractionation in Parkinson's Disease
    Nyholm, Dag
    Stepien, Victoria
    JOURNAL OF PARKINSONS DISEASE, 2014, 4 (01) : 89 - 96
  • [34] Levodopa in the treatment of Parkinson's disease
    Schapira, A. H. V.
    Emre, M.
    Jenner, P.
    Poewe, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (09) : 982 - 989
  • [35] Levodopa, ayurveda and Parkinson's disease
    Deleu, D
    Hanssens, Y
    Northway, MG
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 184 (01) : 89 - 90
  • [36] Levodopa in the treatment of Parkinson's disease
    Koller, WC
    NEUROLOGY, 2000, 55 (11) : S2 - S7
  • [37] Levodopa in the treatment of Parkinson's disease
    Fahn, S.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2006, (71): : 1 - 15
  • [38] The effect of levodopa on voice in Parkinson disease
    Lo, R. Y.
    Lin, S.
    Lee, G.
    Kuo, T. B.
    Chen, S.
    MOVEMENT DISORDERS, 2006, 21 : S492 - S492
  • [39] Levodopa and the progression of Parkinson's disease
    Fahn, S
    Shoulson, I
    Kieburtz, K
    Rudolph, A
    Lang, A
    Olanow, CW
    Tanner, C
    Marek, K
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24): : 2498 - 2508
  • [40] Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease
    Fabbri, Margherita
    Guimaraes, Isabel
    Cardoso, Rita
    Coelho, Miguel
    Guedes, Leonor Correia
    Rosa, Mario M.
    Godinho, Catarina
    Abreu, Daisy
    Goncalves, Nilza
    Antonini, Angelo
    Ferreira, Joaquim J.
    FRONTIERS IN NEUROLOGY, 2017, 8